A Potent and Selective CDKL5/GSK3 Chemical Probe is Neuroprotective.
Ontology highlight
ABSTRACT: Despite mediating several essential processes in the brain, including during development, cyclin-dependent kinase-like 5 (CDKL5) remains a poorly characterized human protein kinase. Accordingly, its substrates, functions, and regulatory mechanisms have not been fully described. We realized that availability of a potent and selective small molecule probe targeting CDKL5 could enable illumination of its roles in normal development as well as in diseases where it has become aberrant due to mutation. We prepared analogs of AT-7519, a known inhibitor of several cyclin dependent and cyclin-dependent kinase-like kinases that has been advanced into Phase II clinical trials. We identified analog 2 as a highly potent and cell-active chemical probe for CDKL5/GSK3 (glycogen synthase kinase 3).
SUBMITTER: Ong HW
PROVIDER: S-EPMC9934649 | biostudies-literature | 2023 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA